EUVIMEDFaigh amach EUVIMED
Open access

TXNDC12 inhibits pancreatic tumor cells ferroptosis by regulating GSH/GGT7 and promotes its growth and metastasis

Xiangrong Xu, Yu Hei, Bobo Wang, Shuyue Tian, Xuanyu Chen, Jing Zhang, Fenghui Wang

Journal of Cancer · 2024 · 15 (12) · 3913-3929

DOI: 10.7150/jca.93208 ↗

At a glance

Journal article in Journal of Cancer, 2024. Written by Xiangrong Xu and 6 co-authors. Institution: Yan'an University College of Basic Medical Sciences, Yan'an, 716000, China. Cited 7 times so far (Crossref). The full text is freely available in PubMed Central.

AchoimreSubjectsSonraí leabharliostaCiteRelated studies

Abstract (original language)

Background

Thioredoxin domain-containing protein 12 (TXNDC12) is upregulated in a variety of tumours, including pancreatic cancer (PAAD), and its high expression is closely associated with poor prognosis. However, the regulatory mechanism of TXNDC12 in PAAD has not been reported. The aim of this study is to reveal the precise mechanism of TXNDC12 in regulating PAAD progression.

Methods

The expression of TXNDC12 in pan-cancer as well as PAAD was verified by TCGA and GTEx databases, Western blot and RT-qPCR. CCK8 assay, clone formation assay and cell cycle assay were used to observe the effect of TXNDC12 on the proliferation of PAAD cells, the migration and invasion capacities were verified by wound healing assay and Transwell assay. The effect of TXNDC12 on apoptosis of MIA PaCa-2 and PANC-1 cells was detected using Hochest and flow cytometry. Finally, the interaction of TXNDC12 with GGT7 was predicted by STRING database and confirmed by CO-IP assay, the effect of TXNDC12 on ferroptosis through GGT7 was evaluated by GSH assay, MDA assay, ROS assay and Western blot.

Results

TXNDC12 is upregulated in PAAD tissues, and patients with high TXNDC12 levels generally have shorter survival times. Knockdown of TXNDC12 significantly inhibited the proliferation, migration and invasion and promoted apoptosis of MIA PaCa-2 and PANC-1 cells. Mechanistically, knockdown of TXNDC12 resulted in a decrease in intracellular GSH content and an increase in GSSG content, as well as elevated levels of pro-ferroptosis factors, such as MDA and ROS. STRING database predicted that TXNDC12 interacts with GGT7, and CO-IP assay was used to validate this result. Finally, the effect of knocking down TXNDC12 on pancreatic cancer cell functions was able to be reversed by overexpression of GGT7.

Conclusion

TXNDC12 inhibits ferroptosis in PAAD cells through the GSH/GGT7 axis thereby promoting their development.

Subjects

Author keywords

GGT7GSHTXNDC12ferroptosispancreatic cancerprogression

Authors and institutions

  • Yan'an University College of Basic Medical Sciences, Yan'an, 716000, China.
  • Yan 'an City fungi resources Development and biological control key laboratory, Yan'an 716000, China.

Cite

APA

Xu, X., Hei, Y., Wang, B., Tian, S., Chen, X., Zhang, J., & Wang, F. (2024). TXNDC12 inhibits pancreatic tumor cells ferroptosis by regulating GSH/GGT7 and promotes its growth and metastasis. Journal of Cancer, 15(12), 3913-3929. https://doi.org/10.7150/jca.93208

Vancouver

Xu X, Hei Y, Wang B, Tian S, Chen X, Zhang J, et al. TXNDC12 inhibits pancreatic tumor cells ferroptosis by regulating GSH/GGT7 and promotes its growth and metastasis. Journal of Cancer. 2024;15(12):3913-3929. doi:10.7150/jca.93208

BibTeX
@article{Xu2024,
  author = {Xu, Xiangrong and Hei, Yu and Wang, Bobo and Tian, Shuyue and Chen, Xuanyu and Zhang, Jing and Wang, Fenghui},
  title = {TXNDC12 inhibits pancreatic tumor cells ferroptosis by regulating GSH/GGT7 and promotes its growth and metastasis},
  journal = {Journal of Cancer},
  year = {2024},
  volume = {15},
  number = {12},
  pages = {3913--3929},
  doi = {10.7150/jca.93208}
}
Start for free →